162 related articles for article (PubMed ID: 21883140)
21. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract][Full Text] [Related]
22. Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.
Nakamura S; Ponzoni M
Pathology; 2020 Jan; 52(1):15-29. PubMed ID: 31757436
[TBL] [Abstract][Full Text] [Related]
23. State-of-the-art therapeutics: marginal-zone lymphoma.
Bertoni F; Zucca E
J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
[TBL] [Abstract][Full Text] [Related]
24. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.
Vela V; Juskevicius D; Dirnhofer S; Menter T; Tzankov A
Virchows Arch; 2022 Feb; 480(2):403-413. PubMed ID: 34494161
[TBL] [Abstract][Full Text] [Related]
25. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract][Full Text] [Related]
26. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
[TBL] [Abstract][Full Text] [Related]
27. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in understanding the biology of marginal zone lymphoma.
Bertoni F; Rossi D; Zucca E
F1000Res; 2018; 7():406. PubMed ID: 29657712
[TBL] [Abstract][Full Text] [Related]
29. Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.
Ayyappan S; William BM
Curr Oncol Rep; 2018 Mar; 20(4):33. PubMed ID: 29572581
[TBL] [Abstract][Full Text] [Related]
30. Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma.
Traverse-Glehen A; Bertoni F; Thieblemont C; Zucca E; Coiffier B; Berger F; Salles G
Oncology (Williston Park); 2012 Jan; 26(1):92-9, 103-4. PubMed ID: 22393802
[TBL] [Abstract][Full Text] [Related]
31. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
32. The many faces of marginal zone lymphoma.
Zinzani PL
Hematology Am Soc Hematol Educ Program; 2012; 2012():426-32. PubMed ID: 23233614
[TBL] [Abstract][Full Text] [Related]
33. Management of Marginal Zone Lymphoma: A Canadian Perspective.
Peters A; Keating MM; Nikonova A; Doucette S; Prica A
Curr Oncol; 2023 Feb; 30(2):1745-1759. PubMed ID: 36826096
[TBL] [Abstract][Full Text] [Related]
34. Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).
Auñón C; Sanvisens A; Turon E; Vidal-Vila A; Puigdemont M; Osca-Gelis G; Eraso A; Marcos-Gragera R
Cancer Med; 2023 Jun; 12(11):12343-12353. PubMed ID: 37076996
[TBL] [Abstract][Full Text] [Related]
35. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
36. Marginal Zone Lymphomas.
Bertoni F; Rossi D; Raderer M; Zucca E
Cancer J; 2020; 26(4):336-347. PubMed ID: 32732678
[TBL] [Abstract][Full Text] [Related]
37. Primary gastric lymphomas (MALTomas): a nuclear image analysis comparison with lymph node monocytoid B-cells and marginal zones of spleen and Peyer's patches.
Spina D; del Vecchio MT; Leoncini L; Vindigni C; Minacci C; Valente G; Palestro G; Tosi P
Anal Cell Pathol; 1995 Jun; 8(4):307-21. PubMed ID: 7577746
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and environmental aspects of marginal zone lymphomas.
Sriskandarajah P; Dearden CE
Best Pract Res Clin Haematol; 2017; 30(1-2):84-91. PubMed ID: 28288721
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous marginal zone B-cell lymphomas: are they different from other extranodal marginal zone B-cell lymphomas?
Ferenczi K
J Cutan Pathol; 2009 Jun; 36(6):715-7. PubMed ID: 19515055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]